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Introduction. Medical physicists planning radiation treatment are increasingly confronted with situations that require 
special attention. Undoubtedly, one such situation is the postoperative irradiation of a patient with breast cancer in which 
there is a prosthesis or an expander. In recent years, expanders have appeared in this location, which, due to the density 
of the device’s valve makes it difficult to prepare an acceptable treatment plan. The study aims to present treatment 
planning in these situation in various Polish cancer centres and to compare overall patient preparation for the treatment.
Material and methods. A questionnaire was prepared and sent to more than 20 radiotherapy departments, which 
included basic questions regarding the preparation of an irradiation plan for patients treated for breast cancer after 
a subcutaneous mastectomy with immediate reconstruction with a prosthesis or expander. The survey encompassed 
eight radiotherapy departments. 
Results. Not all radiotherapy departments require a manufacturer’s certificate, which shows that the manufacturer does 
not prohibit the use of  a prosthesis/expander during treatment with ionizing radiation. The X 6MV photons and the supine 
position, total and fraction doses: from 40 to 60 Gy and from 2 to 2.67 Gy, respectively, are the most commonly used. The 
way of defining them also depends on the oncological centre. The most commonly used irradiation technique is VMAT. 
Conclusion. The conclusion from the questionnaire – no standardisation of treatment planning – should encourage the 
community, at least medical physicists, to develop rules of conduct in this case. Irradiation techniques are mainly dynamic 
ones. The expander or prosthesis does not significantly affect the dose distributions.
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Introduction 
Irradiation of patients with breast cancer is well-established. 
It has a positive effect on local control, but also on long-term 
survival, which has been proven in many clinical studies [1, 2]. 
The use of radiotherapy in these patients has a long tradition. 
The arrangement, due to the anatomy of the patients, were 
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two opposite fields. At that time, this technique and an energy 
of 250 KeV were used. In the 1970s, in Poland, cobalt machines 
started to be used in radiotherapy. In this case, the technique of 
“tangential” open fields was supplemented with wedge filters. 
Instead of two fields, there were four – two open and two 
with wedges. Various types of patient immobilisation systems, 
such as breast boards, T-holders, or vacuum mattresses, slowly 
began to enter clinical practice. In the first years of the use of 
linear accelerators, the techniques of irradiating breast cancer 
patients did not change much. The technique of opposite 
fields was still dominant. The situation did not change with the 
implementation of computed tomography (CT) in planning 
and the use of a multi-leaf collimator (MLC) [3, 4]. 
A radical change took place when planning physicists 
got the opportunity to plan a dynamically changing dose 
– intensity-modulated radiotherapy (IMRT) [5]. Slowly but 
surely, the technique of opposite fields was replaced by 
several beams with a dynamic dose change. In recent years, 
the dynamic arc technique (volumetric modulated arc thera-
py – VMAT) has been increasingly used as a technique in the 
irradiation of breast cancer patients [6]. The calculated dose 
distributions are influenced not only by beam geometry but 
also by algorithms used in treatment planning systems. The 
irradiated volume contains different anatomical structures 
with different densities: lung tissue, bones (ribs), and soft 
(glandular and fatty) tissue. While simple algorithms (based 
on the dose decrease as a function of depth and distance 
from the beam axis) give a good approximation of the dose 
distribution in a medium (section) of the same density; at 
the border of mediums of different density they completely 
distort the dose distribution. The currently used algorithms 
take into account most of the physical phenomena related to 
radiation absorption, therefore the calculated and measured 
dose distributions are consistent within the measurement 
uncertainty. Another problem in the irradiation of patients 
with breast cancer is the mobility of the chest wall and the 
increasingly frequent appearance of high-density implants in 
the irradiated volume. The presence of high-density materials 
can be considered in at least three aspects. There are pro-
gram algorithms that calculate dose distributions that have 
upper-density limitations. This means that when planning 
treatment, it is necessary to change this value to an accep-
table value for the algorithm used. This procedure causes 
the calculations to be inconsistent with reality. The presence 
of high-density material alters the energy spectrum at the 
volume boundary, which affects the dose. Finally, artifacts 
make it much harder to properly contour target volumes. 
Artifacts can be reduced using appropriate software or ma-
nually. Typically one calibration curve is used: HU – density 
[7]. The latter issue was the reason for surveying in Polish 
radiotherapy departments regarding the irradiation of breast 
cancer patients after a subcutaneous mastectomy with the 
use of a prosthesis or an expander.
Material and methods
Questionnaire results
The questionnaire prepared by the University of Jan Kocha-
nowski in Kielce, Holycross Cancer Center in Kielce and the 
Polish Society of Medical Physics were sent to more than 20 
Polish radiotherapy departments (RD). Seven RDs that routinely 
use radiotherapy in breast cancer patients after subcutane-
ous mastectomy with the use of a prosthesis or an expander 
responded to it, and one RD that performed this procedure 
several times and had no experience in this field. Therefore, 
they did not answer the questionnaire directly but sent their 
comments, which we will quote in full: 
1. In planning radiotherapy in such cases, the biggest challen-
ge was obtaining a satisfactory dose in the areas between 
the implant and the lung/rib (thin layer) and the second 
the area between the implant and the body surface (es-
sentially skin and subcutaneous tissue/a postoperative 
scar). 
2. The second challenge was the limitation of the treatment 
planning system, which takes Hounsfield Units (HU) values 
to 3000, with the implant material having this parameter 
much higher. We can measure its HU, but the system does 
not accept it anyway and overwrites this value. 
3. Flares caused by the presence of metal clips cause signifi-
cant disturbances in CT, which can significantly disrupt the 
dose distribution. The use of density correcting algorithms 
in CT is of minimal help.
It is a pity that the other RDs, to which the questionnaire 
was sent, did not answer as to why they do not routinely use 
this type of irradiation.
The questionnaire (tab. I) contained questions on formal 
issues (certificates), treatment planning (beam geometry, nor-
malisation, algorithms), and the values  of the total and fraction 
doses used.
Results
The values  presented in the table show that not all RDs require 
a manufacturer’s certificate, showing that the manufacturer 
does not prohibit the use of a prosthesis/expander during 
treatment with ionizing radiation. This is an important aspect 
of therapy. The lack of a certificate in the medical records can 
make the legal assessment of treatment very complicated. It 
would be prudent to require such a certificate before starting 
treatment. The density of the prosthesis or expander may be 
much greater than that of the soft tissue. Six RDs declared that 
the density value was known from the CT examination. The 
most commonly used irradiation technique is VMAT. Interestin-
gly, none of the radiotherapy departments declared that they 
(routinely) used the tangential field technique (fig. 1), perhaps 
they were qualified for the 3DCRT technique).
The most commonly used energy is the X6MV beam. Only 
one radiotherapy department also uses X15MV radiation. The 
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Table I. Questionnaire with answers. Seven sites responded to the questionnaire, the sum of the points in the question is not always equal to seven, as, for 
example, different dose fractionation schemes can be used in one site
Questionnaire concerning radiotherapy treatment planning for a breast cancer patient irradiated after a subcutaneous mastectomy with immediate 
reconstruction with a prosthesis or expander
1. Do you use postoperative radiotherapy in patients after a subcutaneous mastectomy with simultaneous reconstruction?
yes – 6 no – 0
2. Do you use postoperative radiotherapy in patients after a subcutaneous mastectomy with simultaneous reconstruction 
with the use of an expander?
yes – 5 no – 1
3. Do you require the delivery of the prosthesis manufacturer’s or expander’s certificate for the use of radiotherapy?
yes – 5 no – 2
4. Do you have the exact value of the prosthesis/expander density resulting from the tomographic examination?
yes – 6 no – 1





3D-CRT (field in field) 1
hybrid 3D-CRT 20%, VMAT 80% 2
6.What kind of radiation do you use in patients irradiated with a prosthesis or an expander?
photons: X6MV – 5 electrons: 0 mixed photons: X6MV and X15MV – 1
7. What fraction doses do you use in these patients?
1.8 Gy – 1 2 Gy – 4 2.25 Gy – 1 2.5 Gy – 1 2.67 Gy – 1
8. What total doses do you use in these patients?
45 Gy – 1 45 Gy – 1 50 Gy – 3 50.4 Gy – 1 40 Gy – 1 60 Gy – 1
9. How the dose is specified?
point 0
isodose 2: 95%; 98%
volume 2: 100%; 95% PTV
mean 4
minimum 0
other raport ICRU 83
10. How is the patient positioned?
supine position – 6 srone position – 1
11. Do you use skin bolus in these patients?
yes – 2 no – 5







13. At what distances are computed tomography scans?: 1.5; 2 and 3 [mm]
1,5 mm – 1 2,5 mm – 2 3 mm – 5
14. What value of the calculation grid is used in the dose calculation?: 2.5; 3; 5 [mm]
2,5 mm – 5 3 mm – 2
15. Please attach prepared DVH for treated patient
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one reason to be very careful when planning when there is an 
“object” of high density within the delivery volume. Computed 
tomography is performed with distances between the layers 
from 1.5 to 5 mm and the computational grid from 2.5 to 5 mm. 
The questionnaire also asked for a sample DVH. It is difficult to 
discuss and compare dose values on DVH charts when the 
planned total doses are different. Therefore, it is worth looking 
at the anatomical structures that are analysed. All the graphs 
show: PTV, heart, lungs: right and left and their sum, but only one 
has an “expander”. This outline is introduced not to know what 
doses are in it, but to exclude it from the PTV volume because 
it distorts the information about its distribution.
Since the information that we obtained from the question-
naire speaks about differences in dose definition and data 
acquisition from a CT scanner, it is worth analysing how large 
the differences in doses may be.
Discussion 
The total dose, fractional dose and the method of 
its normalisation
Figure 2 shows an example of the dose distribution with an 
expander. Most of the valves used are less than 3000 HU and 
have no significant effect on the dose distributions.
The most frequently planned fraction dose is 2 Gy, and the 
total 50 Gy normalised to the mean dose value in PTV (fig. 3). 
The differences between dose distributions when normalised 
to a mean value or 95% dose in 95% PTV volume are negligible, 
both in PTV/CTV and critical structures.
Fraction and total doses may have a much greater impact 
on the results of treatment. Let us assume α / β = 4 Gy, let us 
assume the administration of a fractionated dose of 50 Gy at 
2 Gy and 2.5 Gy. The biologically equivalent doses (DizoGy2) 
planned total and fraction doses are in the range from 40 to 
60 Gy and from 2 to 2.67 Gy, respectively. The spread is quite 
significant. If we add to this that these doses are normalised 
to the mean value (57% of RDs), the remaining ones to the 
volume (100% or 95%) and dose (98% or 95%), it may turn out 
that despite the records in the treatment card in different RDs 
are the same, but in reality, they differ significantly [8].
The algorithms used to calculate the doses take into ac-
count “almost” all the physical phenomena related to radiation 
absorption. None of the RDs declared that they used the Pencil 
Beam algorithm [9]. Therefore, it is very likely that the obtained 
calculation results are consistent with the actual doses, of course 
within the limits of measurement uncertainty. However, it should 
be remembered that the results refer to absorbed energy, i.e. 
a physical phenomenon. They do not take into account the 
change in the energy spectrum that may occur on the border 

















Figure 1. Percentage of irradiation techniques in patients treated 
for breast cancer after a subcutaneous mastectomy with the use of 
a prosthesis or expander in seven Polish radiotherapy departments
Figure 2. An example of dose distribution with an expander
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will be 50 Gy and 54.2 Gy. These differences may be important 
in the assessment of treatment effects [10]. 
Effect of the calculation grid on the results of the 
dose distribution
Dose distributions were calculated for the calculation grid: 
1 mm and 5 mm, the results indicate that there is a difference 
in the dose distributions, especially in PTV (fig. 4). Significant 
differences occur in the area of  dose escalation (the PTV area 
under the skin) and on the border: chest wall – lungs which 
could be important in the analysis of the correlation between 
the dose and the likelihood of local cure.
There are differences between the calculations perfor-
med by different algorithms. However, they are difficult to 
estimate based on this questionnaire. Since these are al-
gorithms that take into consideration most of the physical 
phenomena, including the boundary effects related to the 
difference in density, it can be assumed that the calculated 
dose distributions are consistent with the measurement 
results. The questionnaire did not include the question of 
whether the dose distribution was verified in the case of 
dynamic techniques before starting treatment. As this is 
a formal requirement, we recognise that all centres comply 
with the applicable regulations.
Figure 3. An example of 50 Gy total dose distribution in PTV. Normalisation to 95% of the dose in 95% PTV (A) and the mean value in PTV (B), 2.5 mm 
dose grid, Acuros v 15.6 algorithm (VMS). In this case, the values  of the maximum, minimum, and average doses differ by no more than 0.2 Gy
Figure 4. DVH for PTV for dose grid of 5 (A) and 1 (B) mm (AAA algorithm, eclipse, VMS). The differences between the minimum, maximum, and average 
doses are in the order of 1 Gy, the values  are higher for a smaller dose grid
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An important aspect of chest area irradiation is respira-
tory mobility. Figure 5 shows the DVH simulating respiratory 
mobility. It seems that in this anatomical location it is justified 
to use the respiratory gating technique (especially full inspi-
ration) or tracking the location of the irradiated area-tracking 
target [11, 12].
A subcutaneous mastectomy with immediate recon-
struction with an expander or prosthesis is becoming more 
common and sometimes replaces breast-conserving surgery 
in the hope that radiotherapy is not necessary. However, irra-
diation should be used in many patients after subcutaneous 
mastectomy. A very thorough diagnostic workup is demanded 
and proper qualification for this surgical procedure. This is 
also a challenge for radiation oncologists and medical physi-
cists. Prospective trials are necessary to ensure that these new 
techniques do not compromise oncologic outcomes[13–16].
Conclusions
The greatest differences in irradiation and irradiation planning 
in patients treated for breast cancer after a subcutaneous ma-
stectomy with the use of a prosthesis or expander between 
radiotherapy departments concern total and fraction doses. 
The irradiation techniques are mainly dynamic techniques 
(VMAT) and the algorithms used take into account most of 
the physical phenomena related to radiation absorption. The 
methods of normalisation do not make any significant diffe-
rences in the dose distributions. The position of the patient 
is very similar across all RDs. Most radiotherapy departments 
require an expander or prosthesis with a manufacturer’s cer-
tificate. This is an important aspect from a formal point of 
view. Most expander valves have a slightly higher density than 
bone. However, differences in chemical composition must be 
taken into consideration. They do not significantly affect the 
dose distributions, however, attention should be paid to the 
disturbances that are introduced. The actual problem is usually 
the lack of information from the manufacturer as to whether 
the material can be used in radiotherapy. We do not know 
if its properties change as a function of the absorbed dose. 
When preparing patients for irradiation, in particular when 
performing computed tomography, the examination protocol 
should be selected to minimise artifacts that may appear. Due 
to the mobility of this area, related to the patient’s breathing. 
The use of respiratory gating, despite the prolongation of the 
therapeutic session, seems to be justified.
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